Clinical Trials
2 trialsNCT04316546 2026-06-05
MK-7075 (Miransertib) in Proteus Syndrome
National Institutes of Health Clinical Center (CC)
Phase 2 Active not recruiting
NCT02594215 2022-06-30
Dose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome
National Institutes of Health Clinical Center (CC)
Phase 1 Completed